From professional translators, enterprises, web pages and freely available translation repositories.
subcutaan of intravenous
subkutan eller intravenös
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
busulfan (intravenous use)
busulfan (intravenous use)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
subcutaan of intravenous gebruik
subkutan eller intravenös användning
Last Update: 2012-04-10
Usage Frequency: 4
Quality:
immunoglobulin for intravenous administration (ivig)
core spc for human normal immunoglobulin for intravenous administration (ivig)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
- intravenous infusion - 130mg/ml -1
- intravenous infusion - 130mg/ ml - 1
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
tritanrix hepb mag in geen geval intravenous worden toegediend.
tritanrix hepb skall under inga omstÄndigheter ges intravenÖst.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
intravenous conditioning treatment prior to hematopoietic progenitor cell transplantation
intravenous conditioning treatment prior to hematopoietic progenitor cell transplantation
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
immunoglobulin for intravenous and/or intramuscular use core spc for human normal
immunoglobulin for intravenous and/ or intramuscular use core spc for human normal
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
immunoglobulin for intravenous and/or intramuscular use note for guidance on the clinical
immunoglobulin for intravenous and/ or intramuscular use note for guidance on the clinical
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
clinical investigation of human normal immunoglobulin for intravenous administration (ivig)
clinical investigation of human normal immunoglobulin for intravenous administration (ivig)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
immunoglobulin for intravenous administration (ivig) core spc for human and anti-d
immunoglobulin for intravenous administration (ivig) core spc for human and anti- d
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
core spc for human anti-d immunoglobulin and human anti-d immunoglobulin for intravenous use
core spc for human anti- d immunoglobulin and human anti- d immunoglobulin for intravenous use
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
richtsnoeren clinical investigation of human anti-d immunoglobulin and human anti-d immunoglobulin for intravenous use
riktlinjedokumentets titel clinical investigation of human anti- d immunoglobulin and human anti- d immunoglobulin for intravenous use
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan gebruik subcutaan of intravenous gebruik
injektionsflaska (glas)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.